ARDSLEY ADVISORY PARTNERS LP - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 18 filers reported holding ACER THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ARDSLEY ADVISORY PARTNERS LP ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$437,000
+8.7%
18,000
-10.0%
0.08%
-16.8%
Q4 2018$402,000
-34.8%
20,0000.0%0.10%
+21.7%
Q3 2018$617,000
+42.8%
20,0000.0%0.08%
+27.7%
Q2 2018$432,000
+11.9%
20,0000.0%0.06%
+12.1%
Q1 2018$386,000
+82.1%
20,000
+30.7%
0.06%
+123.1%
Q4 2017$212,00015,3000.03%
Other shareholders
ACER THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 147,000$3,572,0001.70%
Vivo Capital, LLC 579,051$14,071,0001.40%
Nantahala Capital Management 884,455$21,492,0000.67%
HEARTLAND ADVISORS INC 220,000$5,346,0000.40%
DRIEHAUS CAPITAL MANAGEMENT LLC 387,632$9,419,0000.35%
EMERALD MUTUAL FUND ADVISERS TRUST 125,000$3,038,0000.12%
SPHERA FUNDS MANAGEMENT LTD. 50,000$1,215,0000.11%
ARDSLEY ADVISORY PARTNERS LP 18,000$437,0000.08%
683 Capital Management, LLC 19,367$471,0000.04%
Tibra Equities Europe Ltd 12,232$297,0000.03%
View complete list of ACER THERAPEUTICS INC shareholders